newsfilter
← Latest News
Earnings Call Transcripts·

Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder - MAPLIGHT THERAPEUTICS INC

Good day and welcome to the top line results from Phase 2 of our study for ML004 and Autism Spectrum Disorder. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a que

Company
MAPLIGHT THERAPEUTICS INC
Keywords
MAPLIGHT THERAPEUTICS INC